Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-08-27
1981-02-03
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 250302, 424 1, 424 7, 424 12, G01N 3354, G01N 3358, G01N 3384
Patent
active
042488540
ABSTRACT:
The invention provides a reaction product of chrysotile asbestos with an antigenic serum protein, preferably albumin, that has particular utility as an antigen in producing antibody to asbestos. The reaction product of asbestos with an antigenic serum protein also can be used in a method for producing an antibody toward asbestos by immunizing a laboratory animal with the reaction product, of asbestos and a serum protein, allowing it to remain in the blood of the animal for a sufficient period of time and thereafter recovering antibody globulins from the laboratory animal.
REFERENCES:
Lukens et al., Biol. Abs., vol. 64, 1977, Ab. No. 5278.
Lukens, Biol. Abs., vol. 67, 1979, Ab. No. 51441.
Kagan, Chem. Abs., vol. 87, 1977, Ab. No. 87: 79383e.
Williams, Methods in Immunol & Immunochem., Acd. Press, N.Y., vol. V, 1976, p. 424-437.
Branning A. L.
Fagelson Anna P.
LaPrade J. C.
Sciascia R. S.
The United States of America as represented by the Secretary of
LandOfFree
Production of antibody toward asbestos and immunoassay therewith does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Production of antibody toward asbestos and immunoassay therewith, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of antibody toward asbestos and immunoassay therewith will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-550857